Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain.
about
Comprehensive molecular characterization of human colon and rectal cancerWnt signaling in cancer stem cells and colon cancer metastasisSOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycinEpidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.Ascl2 knockdown results in tumor growth arrest by miRNA-302b-related inhibition of colon cancer progenitor cells.MicroRNA-200 (miR-200) cluster regulation by achaete scute-like 2 (Ascl2): impact on the epithelial-mesenchymal transition in colon cancer cells.Chromosomal copy number aberrations in colorectal metastases resemble their primary counterparts and differences are typically non-recurrentIdentification of metastasis-associated genes in colorectal cancer using metaDE and survival analysisPKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis.The histone variant H2A.X is a regulator of the epithelial-mesenchymal transitionElevated ASCL2 expression is associated with metastasis of osteosarcoma and predicts poor prognosis of the patientsAurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.Phytoestrogens regulate the proliferation and expression of stem cell factors in cell lines of malignant testicular germ cell tumorsAmigo2-upregulation in Tumour Cells Facilitates Their Attachment to Liver Endothelial Cells Resulting in Liver Metastases.Intestinal stem cells - types and markers.Achaete scute-like 2 suppresses CDX2 expression and inhibits intestinal neoplastic epithelial cell differentiation.Roles of Wnt Target Genes in the Journey of Cancer Stem CellsIGF2 knockdown in two colorectal cancer cell lines decreases survival, adhesion and modulates survival-associated genes.Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4/6-mediated survival signals.A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients.MiR expression profiles of paired primary colorectal cancer and metastases by next-generation sequencing.Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer.Loss of the polycomb mark from bivalent promoters leads to activation of cancer-promoting genes in colorectal tumors.Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases.In situ validation of an intestinal stem cell signature in colorectal cancer.RNA sequencing supports distinct reactive oxygen species-mediated pathways of apoptosis by high and low size mass fractions of Bay leaf (Lauris nobilis) in HT-29 cells.A core program of gene expression characterizes cancer metastases.Regulatory activity based risk model identifies survival of stage II and III colorectal carcinoma.Ascl2 activation by YAP1/KLF5 ensures the self-renewability of colon cancer progenitor cells.Support vector machine classifier for prediction of the metastasis of colorectal cancer.Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis.SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent down-regulation of the ASCL2-CXCR4 axis.
P2860
Q24630415-F11993A0-0B1B-4857-875B-26B8EAD6B9F2Q26748552-98B33349-5D8C-4C0C-9BCD-4F0ECC9DC2C9Q28387834-835C4E1D-6708-46C7-A932-C770CF54516FQ34051967-8107F19C-CEA9-4AB4-AA59-341023891100Q34182315-13A264DD-5710-4B02-B3AC-3D5E39E42C12Q34774540-991840F8-D9F3-45C6-B368-37C7FE9BDC52Q35088103-DAD5F5A2-3B00-4E05-9356-DEF56FD3D2D4Q36502358-A011D719-33F4-471B-A623-281EAF35BB23Q36515067-E68BB340-5FAA-49D6-B5DF-0DDD4F223D49Q36587539-81537E58-494E-487E-ADCE-FA04842F2DBFQ37077429-8FA9EF59-BA84-4F6A-BF72-D3F2C7A1BD6DQ37279302-516407DE-EC96-42DB-B082-395D2FBCA3E7Q37296128-541C7299-466E-47D6-BA0B-6089F89A803FQ37685867-4FDC20E8-3347-4EE6-B920-AC907C6F9C00Q38087571-35D5D47C-A8A8-4177-8862-4E02A3EFAC3DQ38260509-CEC360AE-2596-4E22-BFB5-C5A63E6CB3BCQ38557075-7137B031-F6E9-4A3E-BB57-82A607D6A6E8Q38736986-A7B4A189-FBFD-45B4-B433-1688C3EC1549Q38980557-8929E61B-F733-4819-8DBF-750E10111216Q39627905-4E824757-BF35-486E-A07A-8B071B2AA3BCQ41135277-5DD6BCAB-3541-4C85-AEAC-783F16D6B7C8Q41262324-4172C501-1DC2-4CEF-9955-7D38ACDCAD70Q41353471-D908B234-B637-441D-8B34-D3B3A9117FE6Q42718487-A3AFBCF5-315E-4519-AC0D-6ED49DF4CC6CQ46006378-72070DA1-C836-4786-994F-A4E97867066EQ46080136-65064CD7-29CF-460D-97A3-3E16F6026DC6Q46709248-128E96A1-587A-43B6-93B3-78A4DEE957C8Q47118938-30AC3843-C766-4A1F-A45A-B88302F55927Q47144679-4820F529-1754-4182-A1CF-6AC7648BC057Q47220425-47254C7A-485F-41A1-98CD-D4253C272694Q47564348-7E3BDF8C-A162-4C96-B470-7162017BF99DQ52715864-3185E1E1-B99D-4D58-A5EE-1F7FC51F78A1Q53545593-F1C0716D-AA77-4E82-8A30-E4AD6B4A1DC9
P2860
Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Expression of an ASCL2 related ...... metastases with 11p15.5 gain.
@en
Expression of an ASCL2 related ...... metastases with 11p15.5 gain.
@nl
type
label
Expression of an ASCL2 related ...... metastases with 11p15.5 gain.
@en
Expression of an ASCL2 related ...... metastases with 11p15.5 gain.
@nl
prefLabel
Expression of an ASCL2 related ...... metastases with 11p15.5 gain.
@en
Expression of an ASCL2 related ...... metastases with 11p15.5 gain.
@nl
P2093
P50
P356
P1433
P1476
Expression of an ASCL2 related ...... r metastases with 11p15.5 gain
@en
P2093
N Delhomme
P Schirmacher
T Longerich
P304
P356
10.1136/GUT.2009.195701
P407
P577
2010-05-17T00:00:00Z